Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials

OBJECTIVES: Moderately active RA is associated with poor patient outcomes. Despite this, some health systems have restricted access to advanced therapies to those with severe RA. There is also limited evidence of the efficacy of advanced therapies in the moderately active RA population. This post-ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Conaghan, Philip G, Pavelka, Karel, Hsieh, Song-Chou, Bonnington, Terri-Leigh, Kent, Toby C, Marchbank, Katie, Edwards, Christopher J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Concise Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924096/
https://www.ncbi.nlm.nih.gov/pubmed/36794283
http://dx.doi.org/10.1093/rap/rkad017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924096/
https://www.ncbi.nlm.nih.gov/pubmed/36794283
http://dx.doi.org/10.1093/rap/rkad017

Ejemplares similares